{"title":"Higher postoperative complication rates in patients with systemic lupus erythematosus undergoing surgical and obstetric procedures: a nationwide retrospective matched cohort study.","authors":"Francisco Eduardo Silva, Mirhelen Mendes de Abreu","doi":"10.1007/s00296-026-06316-9","DOIUrl":null,"url":null,"abstract":"<p><p>Population-level evidence on postoperative outcomes in systemic lupus erythematosus (SLE) remains limited. To compare postoperative outcomes between patients with SLE and matched controls and identify factors associated with complications and algorithm-defined disease reactivation. We conducted a nationwide retrospective matched cohort study using DATASUS data. Patients with SLE were matched 1:5 to controls by sex, age group, geographic macro-region, preoperative surgical risk, and surgical category. Postoperative outcomes were assessed over 180 days. Multivariable analyses assessed factors associated with outcomes within the SLE cohort. Sensitivity analyses comprised restriction to elective procedures and exclusion of patients classified with cutaneous lupus. The cohort included 1,708 patients with SLE and 8,540 controls. SLE was associated with increased risks of surgical (RR 2.20, 95% CI 1.91-2.54), clinical (RR 3.30, 95% CI 2.53-4.30), infectious (RR 3.66, 95% CI 2.88-4.64), and other procedure- or care-related complications (RR 11.33, 95% CI 6.19-20.76). Among patients undergoing obstetric procedures, SLE was associated with obstetric complications (RR 1.87, 95% CI 1.37-2.54). Within the SLE cohort, cardiovascular risk was independently associated with higher odds of clinical (adjusted OR 2.75, 95% CI 1.36-5.54) and other procedure- or care-related complications (adjusted OR 5.46, 95% CI 1.84-16.18). Associations between SLE and surgical, clinical, and infectious complications remained significant in both sensitivity analyses. Algorithm-defined SLE reactivation occurred in 3.3%. Patients with SLE had higher risks of several postoperative complications than matched controls. The contributions of disease activity and immunosuppressive treatment warrant further investigation.</p>","PeriodicalId":21322,"journal":{"name":"Rheumatology International","volume":"46 10","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13652903/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatology International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00296-026-06316-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Population-level evidence on postoperative outcomes in systemic lupus erythematosus (SLE) remains limited. To compare postoperative outcomes between patients with SLE and matched controls and identify factors associated with complications and algorithm-defined disease reactivation. We conducted a nationwide retrospective matched cohort study using DATASUS data. Patients with SLE were matched 1:5 to controls by sex, age group, geographic macro-region, preoperative surgical risk, and surgical category. Postoperative outcomes were assessed over 180 days. Multivariable analyses assessed factors associated with outcomes within the SLE cohort. Sensitivity analyses comprised restriction to elective procedures and exclusion of patients classified with cutaneous lupus. The cohort included 1,708 patients with SLE and 8,540 controls. SLE was associated with increased risks of surgical (RR 2.20, 95% CI 1.91-2.54), clinical (RR 3.30, 95% CI 2.53-4.30), infectious (RR 3.66, 95% CI 2.88-4.64), and other procedure- or care-related complications (RR 11.33, 95% CI 6.19-20.76). Among patients undergoing obstetric procedures, SLE was associated with obstetric complications (RR 1.87, 95% CI 1.37-2.54). Within the SLE cohort, cardiovascular risk was independently associated with higher odds of clinical (adjusted OR 2.75, 95% CI 1.36-5.54) and other procedure- or care-related complications (adjusted OR 5.46, 95% CI 1.84-16.18). Associations between SLE and surgical, clinical, and infectious complications remained significant in both sensitivity analyses. Algorithm-defined SLE reactivation occurred in 3.3%. Patients with SLE had higher risks of several postoperative complications than matched controls. The contributions of disease activity and immunosuppressive treatment warrant further investigation.
期刊介绍:
RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology.
RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production.
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.